ArticleFrontiers in oncology2022
Fusing hand-crafted and deep-learning features in a convolutional neural network model to identify prostate cancer in pathology images.
Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- LLM-guided expert feature extraction with fusion-based complementary learning network for fish freshness classification using eye images.Scientific reports · 2026Article
- Automated Prostate Cancer Detection on T2-Weighted MRI Using a Dual-Stream Attention Network: A Study on Private Saudi Clinical Data and Public Benchmark Datasets.Journal of clinical medicine · 2026Article
- MS-GATOR: multi-scale graph attention with topological reasoning for segmentation and classification of prostate cancer based on Gleason scores using histopathology images.Scientific reports · 2026Article
- Histopathology-Based Prostate Cancer Classification Using ResNet: A Comprehensive Deep Learning Analysis.Journal of imaging informatics in medicine · 2026Article
- Multimodal-multiscale hybrid fusion network for automated esophageal cancer diagnosis.iScience · 2026Article
- AI-driven precision diagnosis and treatment of prostate cancer: a narrative review.Frontiers in oncology · 2026Review
- Digital Pathology-Based Comparison of PyRadiomics and HistomicsTK for Nuclei Classification in Melanoma Whole Slide Images.International journal of biomedical imaging · 2026Article
- Enhancing deep learning interpretability for hand-crafted feature-guided histologic image classification via weak-to-strong generalization.Journal of medical imaging (Bellingham, Wash.) · 2026Article
- Deep Learning Techniques for Prostate Cancer Analysis and Detection: Survey of the State of the Art.Journal of imaging · 2025Review
- Unveiling key pathomic features for automated diagnosis and Gleason grade estimation in prostate cancer.BMC medical imaging · 2025Article
- Evaluation of an enhanced ResNet-18 classification model for rapid On-site diagnosis in respiratory cytology.BMC cancer · 2025Article
- Computational pathology: A survey review and the way forward.Journal of pathology informatics · 2024Review
- DeXtrusion: automatic recognition of epithelial cell extrusion through machine learning in vivo.Development (Cambridge, England) · 2023Article
- Research progress on deep learning in magnetic resonance imaging-based diagnosis and treatment of prostate cancer: a review on the current status and perspectives.Frontiers in oncology · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Prostate cancer can be diagnosed by prostate biopsy using transectal ultrasound guidance. The high number of pathology images from biopsy tissues is a burden on pathologists, and analysis is subjective and susceptible to inter-rater variability. The use of machine learning techniques could make prostate histopathology diagnostics more precise, consistent, and efficient overall. This paper presents a new classification fusion network model that was created by fusing eight advanced image features: seven hand-crafted features and one deep-learning feature. These features are the scale-invariant feature transform (SIFT), speeded up robust feature (SURF), oriented features from accelerated segment test (FAST) and rotated binary robust independent elementary features (BRIEF) (ORB) of local features, shape and texture features of the cell nuclei, the histogram of oriented gradients (HOG) feature of the cavities, a color feature, and a convolution deep-learning feature. Matching, integrated, and fusion networks are the three essential components of the proposed deep-learning network. The integrated network consists of both a backbone and an additional network. When classifying 1100 prostate pathology images using this fusion network with different backbones (ResNet-18/50, VGG-11/16, and DenseNet-121/201), we discovered that the proposed model with the ResNet-18 backbone achieved the best performance in terms of the accuracy (95.54%), specificity (93.64%), and sensitivity (97.27%) as well as the area under the receiver operating characteristic curve (98.34%). However, each of the assessment criteria for these separate features had a value lower than 90%, which demonstrates that the suggested model combines differently derived characteristics in an effective manner. Moreover, a Grad-CAM++ heatmap was used to observe the differences between the proposed model and ResNet-18 in terms of the regions of interest. This map showed that the proposed model was better at focusing on cancerous cells than ResNet-18. Hence, the proposed classification fusion network, which combines hand-crafted features and a deep-learning feature, is useful for computer-aided diagnoses based on pathology images of prostate cancer. Because of the similarities in the feature engineering and deep learning for different types of pathology images, the proposed method could be used for other pathology images, such as those of breast, thyroid cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.